domain gst fusion protein Search Results


90
Biacore gst-hur fusion protein
Gst Hur Fusion Protein, supplied by Biacore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst-hur fusion protein/product/Biacore
Average 90 stars, based on 1 article reviews
gst-hur fusion protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sugen Inc purified gst fusion protein containing met kinase domain
Purified Gst Fusion Protein Containing Met Kinase Domain, supplied by Sugen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/purified gst fusion protein containing met kinase domain/product/Sugen Inc
Average 90 stars, based on 1 article reviews
purified gst fusion protein containing met kinase domain - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Upstate Biotechnology Inc human p21-binding pak-1 domain (residues 67-150)
Role of Rac GTPase in Sph-1-P–mediated endothelial actin rearrangement and barrier regulation. (a) Bovine pulmonary artery endothelium were incubated with vehicle (v) Sph-1-P (1 μM), for indicated periods of time, or pretreated with PTX (1 μg/ml, 2 hours) and subsequently incubated with Sph-1-P for 1 minute. Cells were lysed, centrifuged, and supernatants were collected. The activated GTP-bound Rac was precipitated by agarose-conjugated human PAK-1 <t>p21-binding</t> domain and immunoblotted by anti-Rac mAb as described in Methods. Total Rac content was detected using cell lysates. These results indicate rapid Sph-1-P–induced Rac activation, which was completely abolished by PTX. (b–g) Bovine endothelium was transfected with either an empty vector (b and e) or a constitutively active HA-tagged Rac construct (Rac V12) (c, d, f, and g) as described in Methods. Shown are subsequent immunofluorescence images (×100) of endothelial cells stained with either Texas red phalloidin for F-actin (b–d) or anti-HA tag Ab for identification of transfected cells (e–g). b and e, c and f, d and g represent matched images. Overexpression of constitutively active Rac V12, but not control vector, significantly enhances polymerized actin staining (arrows) within the cortical ring with the degree of enhancement dependent upon the level of Rac V-12 overexpression.
Human P21 Binding Pak 1 Domain (Residues 67 150), supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human p21-binding pak-1 domain (residues 67-150)/product/Upstate Biotechnology Inc
Average 90 stars, based on 1 article reviews
human p21-binding pak-1 domain (residues 67-150) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sugen Inc purified gst fusion protein containing zap70 kinase domain
Role of Rac GTPase in Sph-1-P–mediated endothelial actin rearrangement and barrier regulation. (a) Bovine pulmonary artery endothelium were incubated with vehicle (v) Sph-1-P (1 μM), for indicated periods of time, or pretreated with PTX (1 μg/ml, 2 hours) and subsequently incubated with Sph-1-P for 1 minute. Cells were lysed, centrifuged, and supernatants were collected. The activated GTP-bound Rac was precipitated by agarose-conjugated human PAK-1 <t>p21-binding</t> domain and immunoblotted by anti-Rac mAb as described in Methods. Total Rac content was detected using cell lysates. These results indicate rapid Sph-1-P–induced Rac activation, which was completely abolished by PTX. (b–g) Bovine endothelium was transfected with either an empty vector (b and e) or a constitutively active HA-tagged Rac construct (Rac V12) (c, d, f, and g) as described in Methods. Shown are subsequent immunofluorescence images (×100) of endothelial cells stained with either Texas red phalloidin for F-actin (b–d) or anti-HA tag Ab for identification of transfected cells (e–g). b and e, c and f, d and g represent matched images. Overexpression of constitutively active Rac V12, but not control vector, significantly enhances polymerized actin staining (arrows) within the cortical ring with the degree of enhancement dependent upon the level of Rac V-12 overexpression.
Purified Gst Fusion Protein Containing Zap70 Kinase Domain, supplied by Sugen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/purified gst fusion protein containing zap70 kinase domain/product/Sugen Inc
Average 90 stars, based on 1 article reviews
purified gst fusion protein containing zap70 kinase domain - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Brandel Inc gst-pde5 binding domain fusion protein
Role of Rac GTPase in Sph-1-P–mediated endothelial actin rearrangement and barrier regulation. (a) Bovine pulmonary artery endothelium were incubated with vehicle (v) Sph-1-P (1 μM), for indicated periods of time, or pretreated with PTX (1 μg/ml, 2 hours) and subsequently incubated with Sph-1-P for 1 minute. Cells were lysed, centrifuged, and supernatants were collected. The activated GTP-bound Rac was precipitated by agarose-conjugated human PAK-1 <t>p21-binding</t> domain and immunoblotted by anti-Rac mAb as described in Methods. Total Rac content was detected using cell lysates. These results indicate rapid Sph-1-P–induced Rac activation, which was completely abolished by PTX. (b–g) Bovine endothelium was transfected with either an empty vector (b and e) or a constitutively active HA-tagged Rac construct (Rac V12) (c, d, f, and g) as described in Methods. Shown are subsequent immunofluorescence images (×100) of endothelial cells stained with either Texas red phalloidin for F-actin (b–d) or anti-HA tag Ab for identification of transfected cells (e–g). b and e, c and f, d and g represent matched images. Overexpression of constitutively active Rac V12, but not control vector, significantly enhances polymerized actin staining (arrows) within the cortical ring with the degree of enhancement dependent upon the level of Rac V-12 overexpression.
Gst Pde5 Binding Domain Fusion Protein, supplied by Brandel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst-pde5 binding domain fusion protein/product/Brandel Inc
Average 90 stars, based on 1 article reviews
gst-pde5 binding domain fusion protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Corning Life Sciences gst-pdz domain fusion proteins
Role of Rac GTPase in Sph-1-P–mediated endothelial actin rearrangement and barrier regulation. (a) Bovine pulmonary artery endothelium were incubated with vehicle (v) Sph-1-P (1 μM), for indicated periods of time, or pretreated with PTX (1 μg/ml, 2 hours) and subsequently incubated with Sph-1-P for 1 minute. Cells were lysed, centrifuged, and supernatants were collected. The activated GTP-bound Rac was precipitated by agarose-conjugated human PAK-1 <t>p21-binding</t> domain and immunoblotted by anti-Rac mAb as described in Methods. Total Rac content was detected using cell lysates. These results indicate rapid Sph-1-P–induced Rac activation, which was completely abolished by PTX. (b–g) Bovine endothelium was transfected with either an empty vector (b and e) or a constitutively active HA-tagged Rac construct (Rac V12) (c, d, f, and g) as described in Methods. Shown are subsequent immunofluorescence images (×100) of endothelial cells stained with either Texas red phalloidin for F-actin (b–d) or anti-HA tag Ab for identification of transfected cells (e–g). b and e, c and f, d and g represent matched images. Overexpression of constitutively active Rac V12, but not control vector, significantly enhances polymerized actin staining (arrows) within the cortical ring with the degree of enhancement dependent upon the level of Rac V-12 overexpression.
Gst Pdz Domain Fusion Proteins, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst-pdz domain fusion proteins/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
gst-pdz domain fusion proteins - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Boston Biochem gst fusion proteins containing full length pax3 or pax3 domains
(A) Pulse labeling with 35 S-met to determine the rate of p53 synthesis in stage1 and stage 3 ESC. Quantitation of 35 S-p53 is described in the supporting online material. (B) Pulse-chase labeling to determine the t 12 of p53 in stage 1 and stage 3 ESC. (C) Quantitation of ubiquitinated p53/total p53 in stage 1 and stage 3 ESC following immunoprecipitation of p53 and immunoblotting using anti-ubiquitin or anti-p53 antibodies. *p<0.05 vs. stage 1. (D) Whole cell extracts of stage 1 or stage 3 ESC were immunoprecipitated using antibodies against p53, Pax3 <t>or</t> <t>Mdm2,</t> and then immunoblotted using antibodies against p53, Pax3, and Mdm2. (E) Schematic diagram of full-length w.t. Pax3, Pax3 structural domains, and a Splotch Pax3 (Sp) protein product that were expressed as <t>GST</t> and FLAG fusion proteins. N-term, amino-terminus of Pax3 through the homeodomain; C-term, carboxy-terminus distal to the homeodomain (including the trans activation domain); DBD, DNA-binding domain (PD through HD); ID, the trans-activation inhibitory domain (amino-terminal to the PD); PD, paired domain; OCT, octapeptide (carboxy-terminal of the PD to amino-terminal of the HD); and HD, homeodomain. The Splotch cDNA deletes exon 4 and lacks coding sequence for part of the PD and the OCT but retains the HD. Numbers refer to amino acid positions of w.t. Pax3. (F) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or GST following incubation of whole cell lysates from stage 1 ESC with GST-Pax3 fusion proteins linked to glutathione-sepharose beads. (G) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or FLAG following incubation of whole cell lysates from stage 1 ESC that had been transiently transfected with plasmids encoding FLAG-tagged Pax3 fusion proteins with antibody against FLAG linked to M2 beads.
Gst Fusion Proteins Containing Full Length Pax3 Or Pax3 Domains, supplied by Boston Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst fusion proteins containing full length pax3 or pax3 domains/product/Boston Biochem
Average 90 stars, based on 1 article reviews
gst fusion proteins containing full length pax3 or pax3 domains - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sugen Inc purified gst fusion protein containing igf-1 kinase domain
(A) Pulse labeling with 35 S-met to determine the rate of p53 synthesis in stage1 and stage 3 ESC. Quantitation of 35 S-p53 is described in the supporting online material. (B) Pulse-chase labeling to determine the t 12 of p53 in stage 1 and stage 3 ESC. (C) Quantitation of ubiquitinated p53/total p53 in stage 1 and stage 3 ESC following immunoprecipitation of p53 and immunoblotting using anti-ubiquitin or anti-p53 antibodies. *p<0.05 vs. stage 1. (D) Whole cell extracts of stage 1 or stage 3 ESC were immunoprecipitated using antibodies against p53, Pax3 <t>or</t> <t>Mdm2,</t> and then immunoblotted using antibodies against p53, Pax3, and Mdm2. (E) Schematic diagram of full-length w.t. Pax3, Pax3 structural domains, and a Splotch Pax3 (Sp) protein product that were expressed as <t>GST</t> and FLAG fusion proteins. N-term, amino-terminus of Pax3 through the homeodomain; C-term, carboxy-terminus distal to the homeodomain (including the trans activation domain); DBD, DNA-binding domain (PD through HD); ID, the trans-activation inhibitory domain (amino-terminal to the PD); PD, paired domain; OCT, octapeptide (carboxy-terminal of the PD to amino-terminal of the HD); and HD, homeodomain. The Splotch cDNA deletes exon 4 and lacks coding sequence for part of the PD and the OCT but retains the HD. Numbers refer to amino acid positions of w.t. Pax3. (F) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or GST following incubation of whole cell lysates from stage 1 ESC with GST-Pax3 fusion proteins linked to glutathione-sepharose beads. (G) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or FLAG following incubation of whole cell lysates from stage 1 ESC that had been transiently transfected with plasmids encoding FLAG-tagged Pax3 fusion proteins with antibody against FLAG linked to M2 beads.
Purified Gst Fusion Protein Containing Igf 1 Kinase Domain, supplied by Sugen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/purified gst fusion protein containing igf-1 kinase domain/product/Sugen Inc
Average 90 stars, based on 1 article reviews
purified gst fusion protein containing igf-1 kinase domain - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Upstate Biotechnology Inc gst-crib domain fusion protein
(A) Pulse labeling with 35 S-met to determine the rate of p53 synthesis in stage1 and stage 3 ESC. Quantitation of 35 S-p53 is described in the supporting online material. (B) Pulse-chase labeling to determine the t 12 of p53 in stage 1 and stage 3 ESC. (C) Quantitation of ubiquitinated p53/total p53 in stage 1 and stage 3 ESC following immunoprecipitation of p53 and immunoblotting using anti-ubiquitin or anti-p53 antibodies. *p<0.05 vs. stage 1. (D) Whole cell extracts of stage 1 or stage 3 ESC were immunoprecipitated using antibodies against p53, Pax3 <t>or</t> <t>Mdm2,</t> and then immunoblotted using antibodies against p53, Pax3, and Mdm2. (E) Schematic diagram of full-length w.t. Pax3, Pax3 structural domains, and a Splotch Pax3 (Sp) protein product that were expressed as <t>GST</t> and FLAG fusion proteins. N-term, amino-terminus of Pax3 through the homeodomain; C-term, carboxy-terminus distal to the homeodomain (including the trans activation domain); DBD, DNA-binding domain (PD through HD); ID, the trans-activation inhibitory domain (amino-terminal to the PD); PD, paired domain; OCT, octapeptide (carboxy-terminal of the PD to amino-terminal of the HD); and HD, homeodomain. The Splotch cDNA deletes exon 4 and lacks coding sequence for part of the PD and the OCT but retains the HD. Numbers refer to amino acid positions of w.t. Pax3. (F) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or GST following incubation of whole cell lysates from stage 1 ESC with GST-Pax3 fusion proteins linked to glutathione-sepharose beads. (G) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or FLAG following incubation of whole cell lysates from stage 1 ESC that had been transiently transfected with plasmids encoding FLAG-tagged Pax3 fusion proteins with antibody against FLAG linked to M2 beads.
Gst Crib Domain Fusion Protein, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst-crib domain fusion protein/product/Upstate Biotechnology Inc
Average 90 stars, based on 1 article reviews
gst-crib domain fusion protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sandoz glutathione stransferase (gst) fusion protein of the fyn sh2 domain
(A) Pulse labeling with 35 S-met to determine the rate of p53 synthesis in stage1 and stage 3 ESC. Quantitation of 35 S-p53 is described in the supporting online material. (B) Pulse-chase labeling to determine the t 12 of p53 in stage 1 and stage 3 ESC. (C) Quantitation of ubiquitinated p53/total p53 in stage 1 and stage 3 ESC following immunoprecipitation of p53 and immunoblotting using anti-ubiquitin or anti-p53 antibodies. *p<0.05 vs. stage 1. (D) Whole cell extracts of stage 1 or stage 3 ESC were immunoprecipitated using antibodies against p53, Pax3 <t>or</t> <t>Mdm2,</t> and then immunoblotted using antibodies against p53, Pax3, and Mdm2. (E) Schematic diagram of full-length w.t. Pax3, Pax3 structural domains, and a Splotch Pax3 (Sp) protein product that were expressed as <t>GST</t> and FLAG fusion proteins. N-term, amino-terminus of Pax3 through the homeodomain; C-term, carboxy-terminus distal to the homeodomain (including the trans activation domain); DBD, DNA-binding domain (PD through HD); ID, the trans-activation inhibitory domain (amino-terminal to the PD); PD, paired domain; OCT, octapeptide (carboxy-terminal of the PD to amino-terminal of the HD); and HD, homeodomain. The Splotch cDNA deletes exon 4 and lacks coding sequence for part of the PD and the OCT but retains the HD. Numbers refer to amino acid positions of w.t. Pax3. (F) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or GST following incubation of whole cell lysates from stage 1 ESC with GST-Pax3 fusion proteins linked to glutathione-sepharose beads. (G) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or FLAG following incubation of whole cell lysates from stage 1 ESC that had been transiently transfected with plasmids encoding FLAG-tagged Pax3 fusion proteins with antibody against FLAG linked to M2 beads.
Glutathione Stransferase (Gst) Fusion Protein Of The Fyn Sh2 Domain, supplied by Sandoz, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glutathione stransferase (gst) fusion protein of the fyn sh2 domain/product/Sandoz
Average 90 stars, based on 1 article reviews
glutathione stransferase (gst) fusion protein of the fyn sh2 domain - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Inserm Transfert glutathione s-transferase (gst) cdna sequences
(A) Pulse labeling with 35 S-met to determine the rate of p53 synthesis in stage1 and stage 3 ESC. Quantitation of 35 S-p53 is described in the supporting online material. (B) Pulse-chase labeling to determine the t 12 of p53 in stage 1 and stage 3 ESC. (C) Quantitation of ubiquitinated p53/total p53 in stage 1 and stage 3 ESC following immunoprecipitation of p53 and immunoblotting using anti-ubiquitin or anti-p53 antibodies. *p<0.05 vs. stage 1. (D) Whole cell extracts of stage 1 or stage 3 ESC were immunoprecipitated using antibodies against p53, Pax3 <t>or</t> <t>Mdm2,</t> and then immunoblotted using antibodies against p53, Pax3, and Mdm2. (E) Schematic diagram of full-length w.t. Pax3, Pax3 structural domains, and a Splotch Pax3 (Sp) protein product that were expressed as <t>GST</t> and FLAG fusion proteins. N-term, amino-terminus of Pax3 through the homeodomain; C-term, carboxy-terminus distal to the homeodomain (including the trans activation domain); DBD, DNA-binding domain (PD through HD); ID, the trans-activation inhibitory domain (amino-terminal to the PD); PD, paired domain; OCT, octapeptide (carboxy-terminal of the PD to amino-terminal of the HD); and HD, homeodomain. The Splotch cDNA deletes exon 4 and lacks coding sequence for part of the PD and the OCT but retains the HD. Numbers refer to amino acid positions of w.t. Pax3. (F) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or GST following incubation of whole cell lysates from stage 1 ESC with GST-Pax3 fusion proteins linked to glutathione-sepharose beads. (G) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or FLAG following incubation of whole cell lysates from stage 1 ESC that had been transiently transfected with plasmids encoding FLAG-tagged Pax3 fusion proteins with antibody against FLAG linked to M2 beads.
Glutathione S Transferase (Gst) Cdna Sequences, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glutathione s-transferase (gst) cdna sequences/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
glutathione s-transferase (gst) cdna sequences - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MaGil IRB Inc gst-pdz fusion proteins magi3 pdz domain #1
(A) Pulse labeling with 35 S-met to determine the rate of p53 synthesis in stage1 and stage 3 ESC. Quantitation of 35 S-p53 is described in the supporting online material. (B) Pulse-chase labeling to determine the t 12 of p53 in stage 1 and stage 3 ESC. (C) Quantitation of ubiquitinated p53/total p53 in stage 1 and stage 3 ESC following immunoprecipitation of p53 and immunoblotting using anti-ubiquitin or anti-p53 antibodies. *p<0.05 vs. stage 1. (D) Whole cell extracts of stage 1 or stage 3 ESC were immunoprecipitated using antibodies against p53, Pax3 <t>or</t> <t>Mdm2,</t> and then immunoblotted using antibodies against p53, Pax3, and Mdm2. (E) Schematic diagram of full-length w.t. Pax3, Pax3 structural domains, and a Splotch Pax3 (Sp) protein product that were expressed as <t>GST</t> and FLAG fusion proteins. N-term, amino-terminus of Pax3 through the homeodomain; C-term, carboxy-terminus distal to the homeodomain (including the trans activation domain); DBD, DNA-binding domain (PD through HD); ID, the trans-activation inhibitory domain (amino-terminal to the PD); PD, paired domain; OCT, octapeptide (carboxy-terminal of the PD to amino-terminal of the HD); and HD, homeodomain. The Splotch cDNA deletes exon 4 and lacks coding sequence for part of the PD and the OCT but retains the HD. Numbers refer to amino acid positions of w.t. Pax3. (F) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or GST following incubation of whole cell lysates from stage 1 ESC with GST-Pax3 fusion proteins linked to glutathione-sepharose beads. (G) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or FLAG following incubation of whole cell lysates from stage 1 ESC that had been transiently transfected with plasmids encoding FLAG-tagged Pax3 fusion proteins with antibody against FLAG linked to M2 beads.
Gst Pdz Fusion Proteins Magi3 Pdz Domain #1, supplied by MaGil IRB Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst-pdz fusion proteins magi3 pdz domain #1/product/MaGil IRB Inc
Average 90 stars, based on 1 article reviews
gst-pdz fusion proteins magi3 pdz domain #1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Role of Rac GTPase in Sph-1-P–mediated endothelial actin rearrangement and barrier regulation. (a) Bovine pulmonary artery endothelium were incubated with vehicle (v) Sph-1-P (1 μM), for indicated periods of time, or pretreated with PTX (1 μg/ml, 2 hours) and subsequently incubated with Sph-1-P for 1 minute. Cells were lysed, centrifuged, and supernatants were collected. The activated GTP-bound Rac was precipitated by agarose-conjugated human PAK-1 p21-binding domain and immunoblotted by anti-Rac mAb as described in Methods. Total Rac content was detected using cell lysates. These results indicate rapid Sph-1-P–induced Rac activation, which was completely abolished by PTX. (b–g) Bovine endothelium was transfected with either an empty vector (b and e) or a constitutively active HA-tagged Rac construct (Rac V12) (c, d, f, and g) as described in Methods. Shown are subsequent immunofluorescence images (×100) of endothelial cells stained with either Texas red phalloidin for F-actin (b–d) or anti-HA tag Ab for identification of transfected cells (e–g). b and e, c and f, d and g represent matched images. Overexpression of constitutively active Rac V12, but not control vector, significantly enhances polymerized actin staining (arrows) within the cortical ring with the degree of enhancement dependent upon the level of Rac V-12 overexpression.

Journal:

Article Title: Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

doi:

Figure Lengend Snippet: Role of Rac GTPase in Sph-1-P–mediated endothelial actin rearrangement and barrier regulation. (a) Bovine pulmonary artery endothelium were incubated with vehicle (v) Sph-1-P (1 μM), for indicated periods of time, or pretreated with PTX (1 μg/ml, 2 hours) and subsequently incubated with Sph-1-P for 1 minute. Cells were lysed, centrifuged, and supernatants were collected. The activated GTP-bound Rac was precipitated by agarose-conjugated human PAK-1 p21-binding domain and immunoblotted by anti-Rac mAb as described in Methods. Total Rac content was detected using cell lysates. These results indicate rapid Sph-1-P–induced Rac activation, which was completely abolished by PTX. (b–g) Bovine endothelium was transfected with either an empty vector (b and e) or a constitutively active HA-tagged Rac construct (Rac V12) (c, d, f, and g) as described in Methods. Shown are subsequent immunofluorescence images (×100) of endothelial cells stained with either Texas red phalloidin for F-actin (b–d) or anti-HA tag Ab for identification of transfected cells (e–g). b and e, c and f, d and g represent matched images. Overexpression of constitutively active Rac V12, but not control vector, significantly enhances polymerized actin staining (arrows) within the cortical ring with the degree of enhancement dependent upon the level of Rac V-12 overexpression.

Article Snippet: After a brief centrifugation to remove the cell debris, 300 μl of supernatants were incubated with human p21-binding PAK-1 domain (residues 67-150), conjugated with agarose (10 μg, 30 minutes; Upstate Biotechnology Inc.).

Techniques: Incubation, Binding Assay, Activation Assay, Transfection, Plasmid Preparation, Construct, Immunofluorescence, Staining, Over Expression

(A) Pulse labeling with 35 S-met to determine the rate of p53 synthesis in stage1 and stage 3 ESC. Quantitation of 35 S-p53 is described in the supporting online material. (B) Pulse-chase labeling to determine the t 12 of p53 in stage 1 and stage 3 ESC. (C) Quantitation of ubiquitinated p53/total p53 in stage 1 and stage 3 ESC following immunoprecipitation of p53 and immunoblotting using anti-ubiquitin or anti-p53 antibodies. *p<0.05 vs. stage 1. (D) Whole cell extracts of stage 1 or stage 3 ESC were immunoprecipitated using antibodies against p53, Pax3 or Mdm2, and then immunoblotted using antibodies against p53, Pax3, and Mdm2. (E) Schematic diagram of full-length w.t. Pax3, Pax3 structural domains, and a Splotch Pax3 (Sp) protein product that were expressed as GST and FLAG fusion proteins. N-term, amino-terminus of Pax3 through the homeodomain; C-term, carboxy-terminus distal to the homeodomain (including the trans activation domain); DBD, DNA-binding domain (PD through HD); ID, the trans-activation inhibitory domain (amino-terminal to the PD); PD, paired domain; OCT, octapeptide (carboxy-terminal of the PD to amino-terminal of the HD); and HD, homeodomain. The Splotch cDNA deletes exon 4 and lacks coding sequence for part of the PD and the OCT but retains the HD. Numbers refer to amino acid positions of w.t. Pax3. (F) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or GST following incubation of whole cell lysates from stage 1 ESC with GST-Pax3 fusion proteins linked to glutathione-sepharose beads. (G) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or FLAG following incubation of whole cell lysates from stage 1 ESC that had been transiently transfected with plasmids encoding FLAG-tagged Pax3 fusion proteins with antibody against FLAG linked to M2 beads.

Journal: PLoS ONE

Article Title: Pax3 Stimulates p53 Ubiquitination and Degradation Independent of Transcription

doi: 10.1371/journal.pone.0029379

Figure Lengend Snippet: (A) Pulse labeling with 35 S-met to determine the rate of p53 synthesis in stage1 and stage 3 ESC. Quantitation of 35 S-p53 is described in the supporting online material. (B) Pulse-chase labeling to determine the t 12 of p53 in stage 1 and stage 3 ESC. (C) Quantitation of ubiquitinated p53/total p53 in stage 1 and stage 3 ESC following immunoprecipitation of p53 and immunoblotting using anti-ubiquitin or anti-p53 antibodies. *p<0.05 vs. stage 1. (D) Whole cell extracts of stage 1 or stage 3 ESC were immunoprecipitated using antibodies against p53, Pax3 or Mdm2, and then immunoblotted using antibodies against p53, Pax3, and Mdm2. (E) Schematic diagram of full-length w.t. Pax3, Pax3 structural domains, and a Splotch Pax3 (Sp) protein product that were expressed as GST and FLAG fusion proteins. N-term, amino-terminus of Pax3 through the homeodomain; C-term, carboxy-terminus distal to the homeodomain (including the trans activation domain); DBD, DNA-binding domain (PD through HD); ID, the trans-activation inhibitory domain (amino-terminal to the PD); PD, paired domain; OCT, octapeptide (carboxy-terminal of the PD to amino-terminal of the HD); and HD, homeodomain. The Splotch cDNA deletes exon 4 and lacks coding sequence for part of the PD and the OCT but retains the HD. Numbers refer to amino acid positions of w.t. Pax3. (F) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or GST following incubation of whole cell lysates from stage 1 ESC with GST-Pax3 fusion proteins linked to glutathione-sepharose beads. (G) Immunoblot using antibodies against p53 (upper panel), Mdm2 (middle panel), or FLAG following incubation of whole cell lysates from stage 1 ESC that had been transiently transfected with plasmids encoding FLAG-tagged Pax3 fusion proteins with antibody against FLAG linked to M2 beads.

Article Snippet: The reaction mixture (20 μl) contained 10 ng GST-p53 (murine), 24 ng E1 (Boston Biochem), 20 ng GST-UbcH5C (Boston Biochem), 150 ng GST-Mdm2 (murine), 10 μg His-ubiquitin (Boston Biochem), plus GST fusion proteins containing full length Pax3 or Pax3 domains.

Techniques: Labeling, Quantitation Assay, Pulse Chase, Immunoprecipitation, Western Blot, Ubiquitin Proteomics, Activation Assay, Binding Assay, Sequencing, Incubation, Transfection

(A) In vitro ubiquitination reactions of GST-p53 with GST-Mdm2 (150 ng), and 0–1600 ng GST-Pax3. Ubiquitination was assayed by immunoblot using 53 antibodies. The position of GST-p53 is indicated by a heavy arrow, and the positions of ubiquitinated p53 are indicated by narrow arrows. (B) In vitro ubiquitination reactions as in (A) except that GST without any Pax3 coding sequences was used. (C) In vitro ubiquitination reactions performed with only GST-Mdm2 or 400 ng GST-Pax3. (D) In vitro ubiquitination reactions of GST-p53 with GST-Mdm2 and 400 ng GST fusion proteins of w.t. Pax3, Pax3 structural domains, or Splotch Pax3. (The GST-p53 and GST-Mdm2 vectors used here encoded murine p53 and Mdm2, although similar results were obtained using human p53 and Mdm2 fusion proteins (data not shown).)

Journal: PLoS ONE

Article Title: Pax3 Stimulates p53 Ubiquitination and Degradation Independent of Transcription

doi: 10.1371/journal.pone.0029379

Figure Lengend Snippet: (A) In vitro ubiquitination reactions of GST-p53 with GST-Mdm2 (150 ng), and 0–1600 ng GST-Pax3. Ubiquitination was assayed by immunoblot using 53 antibodies. The position of GST-p53 is indicated by a heavy arrow, and the positions of ubiquitinated p53 are indicated by narrow arrows. (B) In vitro ubiquitination reactions as in (A) except that GST without any Pax3 coding sequences was used. (C) In vitro ubiquitination reactions performed with only GST-Mdm2 or 400 ng GST-Pax3. (D) In vitro ubiquitination reactions of GST-p53 with GST-Mdm2 and 400 ng GST fusion proteins of w.t. Pax3, Pax3 structural domains, or Splotch Pax3. (The GST-p53 and GST-Mdm2 vectors used here encoded murine p53 and Mdm2, although similar results were obtained using human p53 and Mdm2 fusion proteins (data not shown).)

Article Snippet: The reaction mixture (20 μl) contained 10 ng GST-p53 (murine), 24 ng E1 (Boston Biochem), 20 ng GST-UbcH5C (Boston Biochem), 150 ng GST-Mdm2 (murine), 10 μg His-ubiquitin (Boston Biochem), plus GST fusion proteins containing full length Pax3 or Pax3 domains.

Techniques: In Vitro, Ubiquitin Proteomics, Western Blot